Honoring Representatives of An-Najah Bio-Sciences Unit
Professor Maher Natsheh, An-Najah University President honored the representatives of An- An-Najah Bio-Sciences Unit (NBU).
The Palestinian pharmaceutical industry has recently witnessed a remarkable development in all manufacturing and technical fields through the quality of the manufactured products in Palestine and keeping up with the international quality standards.
However, all the Palestinian medicines are local generics which are manufactured in pharmaceutical forms derived from the original brands. Accordingly, the pharmaceutical companies are requested to perform bioequivalence studies (BE); which are designed to compare the local (generic) with the brand (originator) medicines on healthy volunteers.
And due to the absence of BE service in Palestine, local companies are forced towards carrying out BE studies outside Palestine, which is a waste of effort and energy.
To complete the University role in improving its health services, actively contribute in protecting the Palestinian citizen, advance the pharmaceutical industries and provide the efficient local medicine to the Palestinian citizen at the lowest prices, the University has taken upon itself to launch the "BE Unit" project.
NBU strives to be a lead full-service Contract Research Organization (CRO) in Palestine with a build-up remarkable contribution in best serving the pharmaceutical industry around the globe.
For more information about NBU, please visit the link: